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Summary.-For each of a set of 11 methylcholanthrene-induced sarcomas of BlO
mice, we measured the amount of H-2 antigen by absorption of a specific antiserum,
and the strength of the tumour-specific transplantation antigen by a transplantation
assay, to see whether they are correlated. No obvious correlation was seen. We showed
that cell suspensions of tumours taken directly from the animal are contaminated
by host cells which make a substantial contribution in H-2 assays. Since this contami-
nation was lost after several passages in vitro, the amount of H-2 on tumour cells was
assayed only after such passages.
THAT tumour-specific transplantation
antigens are like normal major histocom-
patibility antigens in several ways has led
to speculation that they are similar mole-
cules (reviewed in Lennox and Sikora,
1977), they both appear on the cell surface,
induce transplantation immunity and are
antigenically diverse. Two kinds ofexperi-
ments seem to support the suggested rela-
tionship. In one, an inverse relationship is
shown between the amount of certain
tumour antigens and normal histocom-
patibility antigens in a set of related
tumours (Haywood and McKhann, 1971;
Ting and Herberman, 1971; Cikes et al.,
1973; Tsakraklides et al., 1974). In the
other, tumour cells are shown to express
normal major or minor histocompatibility
antigens inappropriate to their haplotype
(Martin et al., 1973; Garrido et al., 1976;
Martin et al., 1977).
Apart from the studies of Ffaywood and
McKhann, the quantitative relationship
between H-2 and TSTA on chemically
induced sarcomas has not been exten-
sively studied. There are several reasons
for doing so. Tumours can be induced with
a wide range of easily measured immuno-
genicities, and seem to form a set of very
closely related tumours. Since Haywood
and McKhann had investigated only 5
tumours, 3 of which were not immuno-
genic, we thought it worthwhile to re-
examine the possible relationship of
amounts of tumour-specific transplanta-
tion antigen (TSTA) and H-2 antigen
(hereafter referred to as "H-2") using a
larger collection of tumours with a wide
range of antigenicities. Moreover, it has
recently been shown that host cells in-
filtrate tumours in the animal (Evans,
1972; Kerbel etal., 1975; ProssandKerbel,
1976). Since Haywood and McKhann
measured the amount of H-2 on cell sus-
pensions prepared fromtumourmasses, the
effect of contaminating host cells on mea-
surements of H-2 needed investigation.
MATERIALS AND METHODS
Mouse strains and tumnours.-B1O and
(Bi0xB1O.BR) Fl mice were derived from
breeders supplied by the Laboratory Animal
Centre, Carshalton, and maintained in our
animal house. Tumours were induced by the
s.c. injection of 0 5 mg 3-methylcholanthrene
(MC) (Eastman-Kodak) dissolved in 0-2 ml
trioctanoin (Eastman-Kodak) into the hind
limbs of male or female BiG or B1O.BR mice,
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and appeared in most mice after a mean
interval of 100 days. When the primary
tumours were about 1 cm in diameter, cell
suspensions were prepared aseptically by
removing them and cutting them into small
fragments in 0-25% trypsin (Gibco-Biocult,
Paisley) in 20 ml of Hanks' Balanced salt
solution (HBSS, Gibco-Biocult). The mixture
was incubated at 37°C (stirring constantly
with a magnetic stirrer) for 2 h, the trypsin
solution being changed every 30 min. The
resulting cell suspensions were washed x 3
with HBSS and their viability assessed by
trypan-blue exclusion. All primary tumours
prepared in this way were passaged twice by
s.c. injection of 106 cells into the flank of
syngeneic mice andthen cell suspensions made
as described above were stored in Liquid N2
and used for subsequent passages in mice.
Tumour passage in vivo.-Tumour cells,
106 in 0-2 ml phosphate-buffered saline
(PBS), were injected s.c. into the right flank
of B1O mice of the same sex as the mouse of
the original tumour. Tumours were excised
and suspensions made when the tumour was
6-10 mm in diameter.
Tumour passage in vitro.-Tumour cells
(106) were inoculated into 75 cm2 tissue-
culture flasks containing 20 ml of tissue
culture medium (RPMI 1640, penicillin
100 iu/ml, streptomycin 100 jtg/ml, gluta-
mine 4 mM, 10% heat-inactivated calf serum
(all reagents Gibco-Biocult). When the cells
had grown about 10-fold to confluence, they
were removed from the surface of the flask
after washing once with 0-2% EDTA and
incubated in 0-25% trypsin in 0-2% EDTA at
37°C for 5 min. The cells were then washed
X3 in tissue-culture medium. Cell viability
was assessed by trypan-blue exclusion.
Nomenclature of MC-induced tumours.
Each tumour was labelled to indicate the
mouse strain of origin, the inducing carcino-
gen, the mouse number and the passage
history tn vivo and in vitro. For example,
B1O/MC 6A/9/12 designates Tumour A in
Mouse Number 6 of Strain BlO, induced by
methylcholanthrene, passaged x 9 in vivo
and x 12 in vitro. Another tumour induced
in a different part of the same mouse is
designated BIO/MC 6B etc.
Rejection assayfor tumour-associated trans-
plantation antigens (TSTA).-Mice were im-
munized by s.c. injection of 106 cells, freshly
prepared from MC tumours, into the flank and
subsequent excision of the resulting tumour
after it had reached a diameter of 6-8 mm.
Ten days later immune mice and control mice
were challenged with varying numbers ofcells
by s.c. injection of test cells into the opposite
flank. The relative growth rates of the subse-
quent tumours in the 2 groups of mice were
determined by measuring with calipers the
maximum tumour diameter, one at right-
angles to that, and calculating the mean
tumour diameter. Highly antigenic tumours
showed a considerably reduced growth rate
in the immunized group, although at chal-
lenge doses used in these experiments tumours
grew in all mice. Immunogenicity was
expressed as the antigenic ratio (Basombrio,
1970):
mean tumour diameter in unimmunized mice
mean tumour diameter in immune mice
at 16 days after tumour challenge. An anti-
genic ratio >1-0 indicates protection.
Antisera and serological techniques.-The
amount of H-2 on cell suspensions was
assayed by absorbing anti-H-2 alloantisera
with doubling dilutions of cells and testing
the residual cytotoxicity by 51Cr release from
appropriately labelled lymph-node cells. Anti-
sera (Searle, High Wycombe, England) were
prepared by immunization of mice congenic
for H-2: (anti H-2b: BIO.BR anti-BIO; anti-
H-2k: BlO anti-BIO.BR).
The relative amount of surface antigen
was calculated by determining the number of
cells required to absorb 50% of cytotoxic
activity from the antiserum dilution used.
The ratio of this number to the number of
cells used as standard required to absorb
50% of cytotoxic activity was calculated.
The reciprocal of this number was taken as
the relative amount of surface antigen. The
tumour used as standard (relative amount of
antigen=l 0) was B1O/MC 9. Details of this
procedure are as previously described (Kohler
et al., 1977).
RESULTS
Contamination oftumour cellsuspensions by
host cells
We measured the amount of H-2 con-
tributed by host-cell infiltration of the
tumour mass to cell suspensions prepared
directly from the tumour mass, and after
varying numbers of passages in vitro. To
do this, BlO or BIO.BR tumours were
grown in (BlOx) Fl mice and cell sus-
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pensions prepared from them were assayed
for ability to absorb anti-H-2k or anti-
H-2b sera. This was done with cell suspen-
sions oftumours from the animal and after
various transfers in tissue culture. Absorp-
tion of B1O.BR anti-BIO (anti-H-2b)
serum with B1O/MC 6A/4 tumour-cell sus-
pensions after varying numbers of pas-
sages in vitro is shown in Fig. 1(a). Cell
suspensions of tumours taken directly
from the animal and after 24 h in vitro
absorb a similar amount of anti-H-2b
activity. After 3 passages in vitro the same
number ofcells absorb about halfas much.
A similar absorption capacity was seen
after 6 passages in vitro. Fig. 1(b) shows
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Those made directly after removing the
tumour from the animal or after 24 h in
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TABLE.-Rank Order of Immunogenicities of B1O MC Sarcomas at Various Challenge
Doses. Antigenic Ratios in Parentheses
Challenge dose
2 x 105
MC 6A (10-0)
MC 6B ( 5-0)
MC 9 (3.2)
MC 5 (1-0)
Strongly antigenic
Weakly antigenic
activity, whereas after 3 passages in vitro
absorptionofantibody directed againstthe
haplotype not found on the tumour cells
themselves disappears. After removal of
host cells, the amount of H-2 expressed on
several MC sarcoma lines remained con-
stant for at least 23 passages in vitro.
Immunogenicity of MC-induced Bi0
sarcomas
The antigenicity of each tumour was
defined in terms of its antigenic ratio, the
mean tumour diameter in the controls
divided by that in immunized animals at
16 days after challenge. In the Table the
antigenic ratios ofthecollectionoftumours
from several sets of experiments are
shown. While the values for a given
tumour may vary, the rank order of the
tumours remains roughly the same.
Measurement of H-2 on MC-induced
sarcomas
In order to quantitate and compare the
amount of H-2b antigens on the 11 dif-
ferent MC-induced sarcomas, we needed to
know the reproducibility of our quantita-
tive absorption assay. To find this out we
measured the amount ofH-2bon 2tumours
(B10/MC 6B/4/4 and BIO/MC 5/4/4) in 3
separate absorption experiments. Theanti-
serum and complement dilutions, 51Cr-
labelled target cells and medium were
made independently for each experiment.
Only the tumour suspensions were pre-
pared in one batch, each portion of cells
1 X 106
MC 6B (9.9)
MC 6A (7.6)
MC 2A (5 3)
MC 14 (4.4)
MC 12 (4.3)
MC 13 (4-0)
MC 4 (3.4)
MC 9 (2.5)
MC 7A (2.4)
MC 8 (2 2)
MC 5 (1-.3)
2 5x 106
MC 6B (7.25)
MC 6A (3 9)
MC 12 (3-3)
MC 13 (2-5)
MC 2A (2.3)
MC 14 (2.2)
MC 7A (2.0)
MC 8 (1 7)
MC 9 (1 7)
MC 4 (1.5)
MC 5 (1.0)
used for the first tube in the absorption
series being counted separately.
It was evident that the relative amount
of H-2 on each tumour, compared with
either B0 LNC or with each other, was
fairly constant from one experiment to
another. On the other hand, the number of
cells required to absorb 50% of the cyto-
toxic activity from the diluted antiserum
varies as much as 2-fold between experi-
ments. This result indicated that the
quantity of H-2 could only be reliably
compared and normalized to LNC among
suspensions in the same experiment, i.e.
with the same serum and complement
dilutions.
In a single experiment, we measured the
amount of H-2 on a set of 11 different
MC-induced sarcomas from B1O mice
passed 3 times in vitro. Immuno-
genicity assays had been previously per-
formed and antigenic ratios calculated for
each tumour. The relative amount ofH-2b
vs the antigenic ratio was plotted, each
tumour being represented by a point
(Fig. 2).
Two facts are apparent. The first is that
the tumours vary greatly in their degree of
immunogenicity. The second is that they
vary greatly in the expression of H-2b.
For most of the tumours there is no obvi-
ous correlation between the amount of
H-2b and their degree of immunogenicity.
However, the 2 most strongly immuno-
genic tumours do express relatively little
measurable H-2, while the most weakly
immunogenic tumour expresses a fair
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FIG. 2.-Relationship between immuno-
genicity expressed as antigenic ratio and
the relative amount of H-2 on 11 MC
sarcomas. H-2 quantity related to the
amount present on B10/MC 9. Challenge
dose of 106 cells in rejection assay.
amount. All other weakly immunogenic
and the moderately immunogenic tumours
express a great range of amounts of H-2b.
DISCUSSION
The antigens that appear on tumour
cells are baffling by their diversity. The
idea that these antigens are related to
another diverse set, the major histocom-
patibility antigens, is appealing, and
various kinds of evidence have been pro-
duced in support of it. One ofthe kinds of
antigen discussed in this relationship is the
set of tumour-specific transplantation
antigens of methyleholanthrene-induced
sarcomas ofmice. Haywood and McKhann
(1971) investigated this relationship with
5 tumours of C3H mice, by assaying them
for the amount of H-2 and for their
immunogenicity. In fact they showed that
3 of them were non-immunogenic and had
much H-2, while the 2 immunogenic ones
had less H-2. From this they suggested
that there is an inverse relationship be-
tween these 2 quantities. The implica-
tion was that the two sets of antigens are
carried by molecules that are closely
enough related to compete for expression
on the cell membrane.
Our attempts to test this relationship
with a set of 11 methylcholanthrene-
induced sarcomas of BlO mice have shown
no clear correlation of the amount of H-2
and tumour-specific immunogenicity. To
quantitate H-2 on the tumour cells we
found it essential to eliminate host cells
that infiltrate the tumour mass and may
contribute much of the H-2 measured on
the cell suspension prepared from it. To do
this, we had to passage the cells 3 times in
vitro. We did confirm for several tumours
that cells so passed retained specific
antigenicity.
How reliable are the data in Fig. 2? It
is important to consider this question care-
fully, for we do not have to remove many
points from the graph to leave a fairly
goodinverserelationshipbetweenimmuno-
genicity (measured by antigenic ratio) and
amount of H-2. In fact, if the data from
Tumours 7(A), 8, and12 areignored(only3/
11 tumours), we could make a good case
for this relationship. We can see, however,
no justification for doing this. While the
absolute amounts of H-2 measured on the
various tumours do vary from one experi-
ment to another, their ranking on the basis
of amount of H-2 stays fairly constant.
The same holds true for the measurements
of immunogenicity.
We think that the question whether
tumour-associated antigens or tumour-
specific transplantation antigens are like
major histocompatibility antigens will not
be answered by experiments of this kind.
An answer will come from these experi-
ments that examine this relationship more
directly, either by serological or chemical
techniques. In the end only comparison of
the isolated molecules can settle this
question.
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